Left: Founder Dr Jane Cardosa
Center: Dr Uwe Schlokat
Right: Michelle Gan

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

biopharma industry awards-dinner

Who made the greatest vaccines breakthrough in Asia?

Emily Event News Leave a Comment

Prevention is better than cure, that is the basis of all public health care policy across the world. As the most populated continent in the world, Asia is the home to more than 4.2 billion people, where more than 1.6 billion of them living in tropical climate. Naturally, diseases which grow in this comfortable, warm and humid climate are highly …